fanta.bio Sample: CNhs12235
11490 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| Brd4 SRX5782039 | Leukemia stem cell lines Blood | 632 / 13024 (4.9%) | 484 / 130240 (0.4%) | −324.0 | −324.0 | 13.06 |
| Asxl1 SRX3341232 | ES cells Pluripotent stem cell | 2702 / 13024 (20.7%) | 2434 / 130240 (1.9%) | −324.0 | −324.0 | 11.10 |
| Eomes SRX4904815 | Natural killer cells Blood | 3376 / 13024 (25.9%) | 3374 / 130240 (2.6%) | −324.0 | −324.0 | 10.01 |
| Epitope tags SRX13233372 | Testis Gonad | 1198 / 13024 (9.2%) | 1265 / 130240 (1.0%) | −324.0 | −324.0 | 9.47 |
| Epitope tags SRX7884346 | Acute myeloid leukemia Blood | 834 / 13024 (6.4%) | 1014 / 130240 (0.8%) | −324.0 | −324.0 | 8.22 |
| GFP SRX8244566 | Hematopoietic progenitors Blood | 1201 / 13024 (9.2%) | 1495 / 130240 (1.1%) | −324.0 | −324.0 | 8.03 |
| Med1 SRX3729400 | Hematopoietic progenitors Blood | 961 / 13024 (7.4%) | 1204 / 130240 (0.9%) | −324.0 | −324.0 | 7.98 |
| Epitope tags SRX7884347 | Acute myeloid leukemia Blood | 896 / 13024 (6.9%) | 1174 / 130240 (0.9%) | −324.0 | −324.0 | 7.63 |
| Kdm6a SRX16085105 | Hematopoietic progenitors Blood | 970 / 13024 (7.4%) | 1281 / 130240 (1.0%) | −324.0 | −324.0 | 7.57 |
| Med1 SRX3729401 | Hematopoietic progenitors Blood | 913 / 13024 (7.0%) | 1247 / 130240 (1.0%) | −324.0 | −324.0 | 7.32 |
| Rnf2 SRX7278120 | Hematopoietic progenitors Blood | 845 / 13024 (6.5%) | 1158 / 130240 (0.9%) | −324.0 | −324.0 | 7.30 |
| Kdm6a SRX16085103 | Hematopoietic progenitors Blood | 971 / 13024 (7.5%) | 1359 / 130240 (1.0%) | −324.0 | −324.0 | 7.14 |
| Ikzf1 SRX8994274 | B cells Blood | 942 / 13024 (7.2%) | 1333 / 130240 (1.0%) | −324.0 | −324.0 | 7.07 |
| Brd4 SRX2522377 | Lymphoma cell lines Blood | 986 / 13024 (7.6%) | 1432 / 130240 (1.1%) | −324.0 | −324.0 | 6.89 |
| Rag1 SRX1046534 | Thymocytes Blood | 1458 / 13024 (11.2%) | 2119 / 130240 (1.6%) | −324.0 | −324.0 | 6.88 |
| Brd4 SRX8934799 | B cells Blood | 1197 / 13024 (9.2%) | 1774 / 130240 (1.4%) | −324.0 | −324.0 | 6.75 |
| Bcl11b SRX1649983 | Thymus Blood | 838 / 13024 (6.4%) | 1245 / 130240 (1.0%) | −324.0 | −324.0 | 6.73 |
| Brd4 SRX3729384 | Hematopoietic progenitors Blood | 1366 / 13024 (10.5%) | 2048 / 130240 (1.6%) | −324.0 | −324.0 | 6.67 |
| Brd4 SRX3113705 | CD4+ T cells Blood | 922 / 13024 (7.1%) | 1395 / 130240 (1.1%) | −324.0 | −324.0 | 6.61 |
| Brd4 SRX1465788 | B cells Blood | 1578 / 13024 (12.1%) | 2389 / 130240 (1.8%) | −324.0 | −324.0 | 6.61 |
| Ets1 SRX1881673 | B cells Blood | 1395 / 13024 (10.7%) | 2149 / 130240 (1.7%) | −324.0 | −324.0 | 6.49 |
| Nipbl SRX13845192 | Scid.adh.2c2 Blood | 993 / 13024 (7.6%) | 1551 / 130240 (1.2%) | −324.0 | −324.0 | 6.40 |
| Nipbl SRX13845190 | Scid.adh.2c2 Blood | 1171 / 13024 (9.0%) | 1834 / 130240 (1.4%) | −324.0 | −324.0 | 6.38 |
| Brd4 SRX8934800 | B cells Blood | 908 / 13024 (7.0%) | 1423 / 130240 (1.1%) | −324.0 | −324.0 | 6.38 |
| Ets1 SRX1881674 | B cells Blood | 1345 / 13024 (10.3%) | 2120 / 130240 (1.6%) | −324.0 | −324.0 | 6.34 |
| Spi1 SRX2499698 | Scid.adh.2c2 Blood | 1103 / 13024 (8.5%) | 1740 / 130240 (1.3%) | −324.0 | −324.0 | 6.34 |
| Ets1 SRX2162542 | Pre-B cells Blood | 1286 / 13024 (9.9%) | 2066 / 130240 (1.6%) | −324.0 | −324.0 | 6.22 |
| Rag2 SRX018807 | Thymocytes Blood | 943 / 13024 (7.2%) | 1533 / 130240 (1.2%) | −324.0 | −324.0 | 6.15 |
| Med1 SRX206369 | Pro-B cells Blood | 1323 / 13024 (10.2%) | 2169 / 130240 (1.7%) | −324.0 | −324.0 | 6.10 |
| Ikzf1 SRX149204 | B3 Blood | 964 / 13024 (7.4%) | 1582 / 130240 (1.2%) | −324.0 | −324.0 | 6.09 |
| Myc SRX2522382 | Lymphoma cell lines Blood | 1296 / 13024 (10.0%) | 2140 / 130240 (1.6%) | −324.0 | −324.0 | 6.06 |
| Spi1 SRX2499719 | Scid.adh.2c2 Blood | 1261 / 13024 (9.7%) | 2092 / 130240 (1.6%) | −324.0 | −324.0 | 6.03 |
| Bcl11b SRX12709527 | CD8+ T cells Blood | 1279 / 13024 (9.8%) | 2122 / 130240 (1.6%) | −324.0 | −324.0 | 6.03 |
| Brd4 SRX3113704 | CD4+ T cells Blood | 1400 / 13024 (10.7%) | 2324 / 130240 (1.8%) | −324.0 | −324.0 | 6.02 |
| Rag2 SRX018809 | Thymocytes Blood | 1289 / 13024 (9.9%) | 2144 / 130240 (1.6%) | −324.0 | −324.0 | 6.01 |
| Ikzf1 SRX149203 | B3 Blood | 1094 / 13024 (8.4%) | 1833 / 130240 (1.4%) | −324.0 | −324.0 | 5.97 |
| Nipbl SRX5730170 | B cells Blood | 1293 / 13024 (9.9%) | 2182 / 130240 (1.7%) | −324.0 | −324.0 | 5.93 |
| Runx1 SRX7821112 | Hematopoietic progenitors Blood | 1097 / 13024 (8.4%) | 1865 / 130240 (1.4%) | −324.0 | −324.0 | 5.88 |
| Runx1 SRX1939447 | Lymphoid-primed multipotent progenitors Blood | 1096 / 13024 (8.4%) | 1871 / 130240 (1.4%) | −324.0 | −324.0 | 5.86 |
| Epitope tags SRX3279733 | B cells Blood | 1758 / 13024 (13.5%) | 3015 / 130240 (2.3%) | −324.0 | −324.0 | 5.83 |
| Myc SRX5356999 | Naive B cells Blood | 1621 / 13024 (12.4%) | 2783 / 130240 (2.1%) | −324.0 | −324.0 | 5.82 |
| Runx3 SRX338019 | Natural killer cells Blood | 1060 / 13024 (8.1%) | 1824 / 130240 (1.4%) | −324.0 | −324.0 | 5.81 |
| Epitope tags SRX11667686 | Pre-B cells Blood | 1058 / 13024 (8.1%) | 1823 / 130240 (1.4%) | −324.0 | −324.0 | 5.80 |
| Epitope tags SRX7713738 | Ba/F3 Blood | 989 / 13024 (7.6%) | 1709 / 130240 (1.3%) | −324.0 | −324.0 | 5.79 |
| Nipbl SRX5730168 | B cells Blood | 1302 / 13024 (10.0%) | 2260 / 130240 (1.7%) | −324.0 | −324.0 | 5.76 |
| Smarca4 SRX7807054 | Embryonic liver Embryo | 1704 / 13024 (13.1%) | 2968 / 130240 (2.3%) | −324.0 | −324.0 | 5.74 |
| Brd4 SRX10701688 | Spleen Spleen | 1039 / 13024 (8.0%) | 1822 / 130240 (1.4%) | −324.0 | −324.0 | 5.70 |
| Rag1 SRX1046554 | Unclassified Unclassified | 1249 / 13024 (9.6%) | 2199 / 130240 (1.7%) | −324.0 | −324.0 | 5.68 |
| Brd4 SRX3602883 | iPS cells Pluripotent stem cell | 954 / 13024 (7.3%) | 1683 / 130240 (1.3%) | −324.0 | −324.0 | 5.67 |
| Brd4 SRX3729385 | Hematopoietic progenitors Blood | 1425 / 13024 (10.9%) | 2514 / 130240 (1.9%) | −324.0 | −324.0 | 5.67 |
| Asxl1 SRX3739259 | Bone Marrow Cells Blood | 1529 / 13024 (11.7%) | 2705 / 130240 (2.1%) | −324.0 | −324.0 | 5.65 |
| Med12 SRX5086064 | Th2 Cells Blood | 1000 / 13024 (7.7%) | 1778 / 130240 (1.4%) | −324.0 | −324.0 | 5.62 |
| Smad3 SRX9912241 | CH12 Blood | 1011 / 13024 (7.8%) | 1816 / 130240 (1.4%) | −324.0 | −324.0 | 5.57 |
| Kdm2b SRX22719854 | Leukemia Blood | 1023 / 13024 (7.9%) | 1862 / 130240 (1.4%) | −324.0 | −324.0 | 5.49 |
| Bcl11b SRX1677236 | Thymus Blood | 1088 / 13024 (8.4%) | 1983 / 130240 (1.5%) | −324.0 | −324.0 | 5.49 |
| Hdac1 SRX1815526 | B cells Blood | 1374 / 13024 (10.5%) | 2514 / 130240 (1.9%) | −324.0 | −324.0 | 5.47 |
| Med12 SRX5086066 | Th2 Cells Blood | 1590 / 13024 (12.2%) | 2916 / 130240 (2.2%) | −324.0 | −324.0 | 5.45 |
| Myc SRX2522383 | Lymphoma cell lines Blood | 1586 / 13024 (12.2%) | 2915 / 130240 (2.2%) | −324.0 | −324.0 | 5.44 |
| Men1 SRX415268 | Th2 Cells Blood | 1229 / 13024 (9.4%) | 2263 / 130240 (1.7%) | −324.0 | −324.0 | 5.43 |
| Nipbl SRX320067 | CD4 CD8 double positive cells Blood | 1350 / 13024 (10.4%) | 2491 / 130240 (1.9%) | −324.0 | −324.0 | 5.42 |
| Rag2 SRX1046543 | Thymocytes Blood | 2169 / 13024 (16.7%) | 4005 / 130240 (3.1%) | −324.0 | −324.0 | 5.42 |
| Ets1 SRX5086093 | Th2 Cells Blood | 1387 / 13024 (10.6%) | 2565 / 130240 (2.0%) | −324.0 | −324.0 | 5.41 |
| Epitope tags SRX3219118 | RN2 Blood | 1528 / 13024 (11.7%) | 2848 / 130240 (2.2%) | −324.0 | −324.0 | 5.37 |
| Asxl1 SRX3739258 | Bone Marrow Cells Blood | 1726 / 13024 (13.3%) | 3219 / 130240 (2.5%) | −324.0 | −324.0 | 5.36 |
| Brd4 SRX3602879 | iPS cells Pluripotent stem cell | 1068 / 13024 (8.2%) | 1994 / 130240 (1.5%) | −324.0 | −324.0 | 5.36 |
| Myc SRX353782 | B cells Blood | 1143 / 13024 (8.8%) | 2135 / 130240 (1.6%) | −324.0 | −324.0 | 5.35 |
| Fli1 SRX1056338 | 416B Blood | 1391 / 13024 (10.7%) | 2600 / 130240 (2.0%) | −324.0 | −324.0 | 5.35 |
| Erg SRX310200 | Mast Cells Blood | 1630 / 13024 (12.5%) | 3052 / 130240 (2.3%) | −324.0 | −324.0 | 5.34 |
| Med12 SRX5086065 | Th2 Cells Blood | 1040 / 13024 (8.0%) | 1950 / 130240 (1.5%) | −324.0 | −324.0 | 5.33 |
| Kmt2a SRX17605412 | Leukemia Blood | 1572 / 13024 (12.1%) | 2965 / 130240 (2.3%) | −324.0 | −324.0 | 5.30 |
| Myc SRX5357000 | Naive B cells Blood | 1974 / 13024 (15.2%) | 3740 / 130240 (2.9%) | −324.0 | −324.0 | 5.28 |
| Stat5a SRX2975359 | Natural killer cells Blood | 1413 / 13024 (10.8%) | 2680 / 130240 (2.1%) | −324.0 | −324.0 | 5.27 |
| Erg SRX7821113 | Hematopoietic progenitors Blood | 1348 / 13024 (10.4%) | 2561 / 130240 (2.0%) | −324.0 | −324.0 | 5.26 |
| Nipbl SRX13845191 | Scid.adh.2c2 Blood | 1734 / 13024 (13.3%) | 3302 / 130240 (2.5%) | −324.0 | −324.0 | 5.25 |
| Erg SRX1939438 | Lymphoid-primed multipotent progenitors Blood | 1346 / 13024 (10.3%) | 2564 / 130240 (2.0%) | −324.0 | −324.0 | 5.25 |
| Epitope tags DRX165598 | Unclassified Unclassified | 1300 / 13024 (10.0%) | 2484 / 130240 (1.9%) | −324.0 | −324.0 | 5.23 |
| Nipbl SRX5730166 | B cells Blood | 1728 / 13024 (13.3%) | 3305 / 130240 (2.5%) | −324.0 | −324.0 | 5.23 |
| Bcl11b SRX1677234 | Thymus Blood | 2178 / 13024 (16.7%) | 4167 / 130240 (3.2%) | −324.0 | −324.0 | 5.23 |
| Myc SRX5356998 | Naive B cells Blood | 2055 / 13024 (15.8%) | 3941 / 130240 (3.0%) | −324.0 | −324.0 | 5.21 |
| Ets1 SRX5086097 | Th2 Cells Blood | 1664 / 13024 (12.8%) | 3192 / 130240 (2.5%) | −324.0 | −324.0 | 5.21 |
| Kat2a SRX1815524 | B cells Blood | 1352 / 13024 (10.4%) | 2594 / 130240 (2.0%) | −324.0 | −324.0 | 5.21 |
| Foxp3 SRX3829344 | Treg Blood | 1197 / 13024 (9.2%) | 2297 / 130240 (1.8%) | −324.0 | −324.0 | 5.21 |
| Kmt2a SRX11002576 | Leukemia Blood | 1210 / 13024 (9.3%) | 2322 / 130240 (1.8%) | −324.0 | −324.0 | 5.21 |
| Epitope tags SRX8244557 | Hematopoietic progenitors Blood | 3398 / 13024 (26.1%) | 6524 / 130240 (5.0%) | −324.0 | −324.0 | 5.21 |
| Bcor SRX22719795 | Leukemia Blood | 1645 / 13024 (12.6%) | 3160 / 130240 (2.4%) | −324.0 | −324.0 | 5.21 |
| Hcfc1 SRX22870629 | Hepa 1-6 Liver | 1051 / 13024 (8.1%) | 2020 / 130240 (1.6%) | −324.0 | −324.0 | 5.20 |
| Nipbl SRX8694071 | B cells Blood | 1347 / 13024 (10.3%) | 2614 / 130240 (2.0%) | −324.0 | −324.0 | 5.15 |
| Bcl11a SRX8030787 | Acute myeloid leukemia Blood | 1068 / 13024 (8.2%) | 2073 / 130240 (1.6%) | −324.0 | −324.0 | 5.15 |
| Stat2 SRX2647476 | CD4+ T cells Blood | 1087 / 13024 (8.3%) | 2110 / 130240 (1.6%) | −324.0 | −324.0 | 5.15 |
| Stat2 SRX2647492 | CD4+ T cells Blood | 1063 / 13024 (8.2%) | 2094 / 130240 (1.6%) | −324.0 | −324.0 | 5.08 |
| Epitope tags SRX11667696 | Pre-B cells Blood | 1157 / 13024 (8.9%) | 2284 / 130240 (1.8%) | −324.0 | −324.0 | 5.07 |
| Brd4 SRX7799914 | CH12 Blood | 1802 / 13024 (13.8%) | 3570 / 130240 (2.7%) | −324.0 | −324.0 | 5.05 |
| Ets1 SRX5086094 | Th2 Cells Blood | 2248 / 13024 (17.3%) | 4486 / 130240 (3.4%) | −324.0 | −324.0 | 5.01 |
| Ep300 SRX15950933 | CD4+ T cells Blood | 1425 / 13024 (10.9%) | 2847 / 130240 (2.2%) | −324.0 | −324.0 | 5.01 |
| Nelfb SRX11921266 | Naive T cells Blood | 1195 / 13024 (9.2%) | 2392 / 130240 (1.8%) | −324.0 | −324.0 | 5.00 |
| Spi1 SRX2499699 | Scid.adh.2c2 Blood | 1990 / 13024 (15.3%) | 3988 / 130240 (3.1%) | −324.0 | −324.0 | 4.99 |
| Runx1 SRX1438366 | EML Blood | 2489 / 13024 (19.1%) | 4994 / 130240 (3.8%) | −324.0 | −324.0 | 4.98 |
| Myc SRX353784 | B cells Blood | 1922 / 13024 (14.8%) | 3865 / 130240 (3.0%) | −324.0 | −324.0 | 4.97 |
| Pou2f1 SRX7368547 | B cells Blood | 1134 / 13024 (8.7%) | 2281 / 130240 (1.8%) | −324.0 | −324.0 | 4.97 |
| Kdm2b SRX22719856 | Leukemia Blood | 1853 / 13024 (14.2%) | 3732 / 130240 (2.9%) | −324.0 | −324.0 | 4.97 |
| Ets1 SRX5086095 | Th2 Cells Blood | 1727 / 13024 (13.3%) | 3479 / 130240 (2.7%) | −324.0 | −324.0 | 4.96 |
| Runx1 SRX2499764 | Scid.adh.2c2 Blood | 2216 / 13024 (17.0%) | 4472 / 130240 (3.4%) | −324.0 | −324.0 | 4.96 |
| Myc SRX2417364 | Macrophages Blood | 1071 / 13024 (8.2%) | 2162 / 130240 (1.7%) | −324.0 | −324.0 | 4.95 |
| Kmt2a SRX17605406 | Granulocytic-monocytic progenitors Blood | 2036 / 13024 (15.6%) | 4118 / 130240 (3.2%) | −324.0 | −324.0 | 4.94 |
| Hdac1 SRX7726758 | B cells Blood | 1613 / 13024 (12.4%) | 3265 / 130240 (2.5%) | −324.0 | −324.0 | 4.94 |
| Runx3 SRX8718739 | T progenitor cells Blood | 1659 / 13024 (12.7%) | 3368 / 130240 (2.6%) | −324.0 | −324.0 | 4.93 |
| Nipbl SRX4895107 | CH12 Blood | 1800 / 13024 (13.8%) | 3662 / 130240 (2.8%) | −324.0 | −324.0 | 4.92 |
| N6amt1 SRX8338674 | Tumour organoids Others | 1272 / 13024 (9.8%) | 2590 / 130240 (2.0%) | −324.0 | −324.0 | 4.91 |
| Nipbl SRX8694069 | B cells Blood | 1604 / 13024 (12.3%) | 3270 / 130240 (2.5%) | −324.0 | −324.0 | 4.91 |
| Runx1 DRX165596 | Unclassified Unclassified | 1418 / 13024 (10.9%) | 2891 / 130240 (2.2%) | −324.0 | −324.0 | 4.90 |
| Hdac1 SRX7726757 | B cells Blood | 1146 / 13024 (8.8%) | 2339 / 130240 (1.8%) | −324.0 | −324.0 | 4.90 |
| Pou2f1 SRX7368548 | B cells Blood | 1145 / 13024 (8.8%) | 2340 / 130240 (1.8%) | −324.0 | −324.0 | 4.89 |
| Taf12 SRX11221943 | ES cells Pluripotent stem cell | 1114 / 13024 (8.6%) | 2281 / 130240 (1.8%) | −324.0 | −324.0 | 4.88 |
| Runx1 SRX5358496 | Pro-B cells Blood | 2890 / 13024 (22.2%) | 5930 / 130240 (4.6%) | −324.0 | −324.0 | 4.87 |
| Runx3 SRX8718716 | T progenitor cells Blood | 1693 / 13024 (13.0%) | 3474 / 130240 (2.7%) | −324.0 | −324.0 | 4.87 |
| Brd4 SRX10701687 | Spleen Spleen | 1299 / 13024 (10.0%) | 2674 / 130240 (2.1%) | −324.0 | −324.0 | 4.86 |
| Epitope tags SRX3279734 | B cells Blood | 2674 / 13024 (20.5%) | 5513 / 130240 (4.2%) | −324.0 | −324.0 | 4.85 |
| Cbfb SRX2389671 | Embryonic liver Embryo | 1970 / 13024 (15.1%) | 4062 / 130240 (3.1%) | −324.0 | −324.0 | 4.85 |
| Nipbl SRX5730169 | B cells Blood | 1711 / 13024 (13.1%) | 3528 / 130240 (2.7%) | −324.0 | −324.0 | 4.85 |
| Spi1 SRX5507842 | Spleen and lymph nodes Blood | 1410 / 13024 (10.8%) | 2910 / 130240 (2.2%) | −324.0 | −324.0 | 4.85 |
| Med12 SRX5086068 | Th2 Cells Blood | 1481 / 13024 (11.4%) | 3057 / 130240 (2.3%) | −324.0 | −324.0 | 4.84 |
| Bcl11b SRX1649982 | Thymus Blood | 2331 / 13024 (17.9%) | 4814 / 130240 (3.7%) | −324.0 | −324.0 | 4.84 |
| Cbfb SRX5780109 | CD4+ T cells Blood | 1267 / 13024 (9.7%) | 2618 / 130240 (2.0%) | −324.0 | −324.0 | 4.84 |
| Nipbl SRX8694068 | B cells Blood | 1476 / 13024 (11.3%) | 3051 / 130240 (2.3%) | −324.0 | −324.0 | 4.84 |
| Pcgf1 DRX053276 | MEL Blood | 1261 / 13024 (9.7%) | 2627 / 130240 (2.0%) | −324.0 | −324.0 | 4.80 |
| Rad21 SRX7481995 | Pro-B cells Blood | 1641 / 13024 (12.6%) | 3421 / 130240 (2.6%) | −324.0 | −324.0 | 4.80 |
| Epitope tags SRX2486172 | ES cells Pluripotent stem cell | 1408 / 13024 (10.8%) | 2938 / 130240 (2.3%) | −324.0 | −324.0 | 4.79 |
| Nipbl SRX5730164 | CH12F3 Blood | 1602 / 13024 (12.3%) | 3347 / 130240 (2.6%) | −324.0 | −324.0 | 4.79 |
| Runx1 SRX2499765 | Scid.adh.2c2 Blood | 1815 / 13024 (13.9%) | 3795 / 130240 (2.9%) | −324.0 | −324.0 | 4.78 |
| Ep300 SRX7726474 | Natural killer cells Blood | 1196 / 13024 (9.2%) | 2506 / 130240 (1.9%) | −324.0 | −324.0 | 4.77 |
| Nipbl SRX5730171 | B cells Blood | 1744 / 13024 (13.4%) | 3662 / 130240 (2.8%) | −324.0 | −324.0 | 4.76 |
| Rag2 SRX1046550 | B cells Blood | 2723 / 13024 (20.9%) | 5721 / 130240 (4.4%) | −324.0 | −324.0 | 4.76 |
| Epitope tags SRX24288475 | Pro-B cells Blood | 1342 / 13024 (10.3%) | 2820 / 130240 (2.2%) | −324.0 | −324.0 | 4.76 |
| Phf8 SRX15939565 | NIH/3T3 Embryonic fibroblast | 1283 / 13024 (9.9%) | 2701 / 130240 (2.1%) | −324.0 | −324.0 | 4.75 |
| Epitope tags SRX2357488 | Embryonic kidney Embryo | 1214 / 13024 (9.3%) | 2556 / 130240 (2.0%) | −324.0 | −324.0 | 4.75 |
| Bach2 SRX2200546 | Pro-B cells Blood | 1703 / 13024 (13.1%) | 3594 / 130240 (2.8%) | −324.0 | −324.0 | 4.74 |
| Runx1 SRX2499763 | Scid.adh.2c2 Blood | 1316 / 13024 (10.1%) | 2782 / 130240 (2.1%) | −324.0 | −324.0 | 4.73 |
| Rag2 SRX1046552 | B cells Blood | 2436 / 13024 (18.7%) | 5151 / 130240 (4.0%) | −324.0 | −324.0 | 4.73 |
| Spi1 SRX2499700 | Scid.adh.2c2 Blood | 1590 / 13024 (12.2%) | 3364 / 130240 (2.6%) | −324.0 | −324.0 | 4.73 |
| GFP SRX2486160 | C127 Breast | 1622 / 13024 (12.5%) | 3436 / 130240 (2.6%) | −324.0 | −324.0 | 4.72 |
| Ikzf1 SRX692974 | CD4 CD8 double negative cells Blood | 1430 / 13024 (11.0%) | 3031 / 130240 (2.3%) | −324.0 | −324.0 | 4.72 |
| Bcl11b SRX1677239 | Thymus Blood | 2296 / 13024 (17.6%) | 4875 / 130240 (3.7%) | −324.0 | −324.0 | 4.71 |
| Tet2 SRX1387481 | MEL Blood | 1447 / 13024 (11.1%) | 3075 / 130240 (2.4%) | −324.0 | −324.0 | 4.71 |
| Pax5 SRX19312223 | Pro-B cells Blood | 1912 / 13024 (14.7%) | 4066 / 130240 (3.1%) | −324.0 | −324.0 | 4.70 |
| Phf8 SRX15939564 | NIH/3T3 Embryonic fibroblast | 1244 / 13024 (9.6%) | 2646 / 130240 (2.0%) | −324.0 | −324.0 | 4.70 |
| Myc SRX353783 | B cells Blood | 2454 / 13024 (18.8%) | 5223 / 130240 (4.0%) | −324.0 | −324.0 | 4.70 |
| Men1 SRX415267 | Th2 Cells Blood | 1669 / 13024 (12.8%) | 3558 / 130240 (2.7%) | −324.0 | −324.0 | 4.69 |
| Stat4 SRX7726477 | Natural killer cells Blood | 1710 / 13024 (13.1%) | 3647 / 130240 (2.8%) | −324.0 | −324.0 | 4.69 |
| Rad21 SRX23052807 | mESC derived neural cells Pluripotent stem cell | 1392 / 13024 (10.7%) | 2972 / 130240 (2.3%) | −324.0 | −324.0 | 4.68 |
| Bcl11b SRX18851332 | Thymocytes Blood | 2317 / 13024 (17.8%) | 4947 / 130240 (3.8%) | −324.0 | −324.0 | 4.68 |
| Brd4 SRX3602867 | iPS cells Pluripotent stem cell | 1288 / 13024 (9.9%) | 2750 / 130240 (2.1%) | −324.0 | −324.0 | 4.68 |
| Kmt2a SRX22719786 | Leukemia Blood | 1527 / 13024 (11.7%) | 3263 / 130240 (2.5%) | −324.0 | −324.0 | 4.68 |
| Rad21 SRX7508562 | Pro-B cells Blood | 1268 / 13024 (9.7%) | 2722 / 130240 (2.1%) | −324.0 | −324.0 | 4.66 |
| Nipbl SRX8694070 | B cells Blood | 1448 / 13024 (11.1%) | 3109 / 130240 (2.4%) | −324.0 | −324.0 | 4.66 |
| Bcl11b SRX2487650 | CD4 CD8 double negative cells Blood | 2661 / 13024 (20.4%) | 5714 / 130240 (4.4%) | −324.0 | −324.0 | 4.66 |
| Nipbl SRX5730167 | B cells Blood | 1662 / 13024 (12.8%) | 3572 / 130240 (2.7%) | −324.0 | −324.0 | 4.65 |
| Ets1 SRX5086099 | Th2 Cells Blood | 2108 / 13024 (16.2%) | 4533 / 130240 (3.5%) | −324.0 | −324.0 | 4.65 |
| Cbfb SRX5780111 | CD8+ T cells Blood | 1756 / 13024 (13.5%) | 3780 / 130240 (2.9%) | −324.0 | −324.0 | 4.65 |
| Spi1 SRX5026209 | Mast Cells Blood | 1212 / 13024 (9.3%) | 2612 / 130240 (2.0%) | −324.0 | −324.0 | 4.64 |
| Epitope tags SRX9195285 | ES cells Pluripotent stem cell | 1179 / 13024 (9.1%) | 2551 / 130240 (2.0%) | −324.0 | −324.0 | 4.62 |
| Biotin SRX5578684 | ES cells Pluripotent stem cell | 1225 / 13024 (9.4%) | 2656 / 130240 (2.0%) | −324.0 | −324.0 | 4.61 |
| Kmt2a SRX25655412 | Leukemia Blood | 1341 / 13024 (10.3%) | 2908 / 130240 (2.2%) | −324.0 | −324.0 | 4.61 |
| Runx1 SRX2789670 | Natural Killer T-Cells Blood | 1887 / 13024 (14.5%) | 4095 / 130240 (3.1%) | −324.0 | −324.0 | 4.61 |
| Rag2 SRX1046542 | Thymocytes Blood | 2832 / 13024 (21.7%) | 6187 / 130240 (4.8%) | −324.0 | −324.0 | 4.58 |
| Nelfe SRX140395 | MEL Blood | 1656 / 13024 (12.7%) | 3622 / 130240 (2.8%) | −324.0 | −324.0 | 4.57 |
| Ep300 SRX25655383 | Leukemia Blood | 1673 / 13024 (12.8%) | 3680 / 130240 (2.8%) | −324.0 | −324.0 | 4.55 |
| Ets1 SRX2499706 | Scid.adh.2c2 Blood | 2707 / 13024 (20.8%) | 5960 / 130240 (4.6%) | −324.0 | −324.0 | 4.54 |
| Med23 SRX20509321 | CH12 Blood | 1501 / 13024 (11.5%) | 3305 / 130240 (2.5%) | −324.0 | −324.0 | 4.54 |
| Spi1 SRX091672 | CD4 CD8 double negative cells Blood | 1804 / 13024 (13.9%) | 3974 / 130240 (3.1%) | −324.0 | −324.0 | 4.54 |
| Ets1 SRX5086098 | Th2 Cells Blood | 2482 / 13024 (19.1%) | 5474 / 130240 (4.2%) | −324.0 | −324.0 | 4.53 |
| Epitope tags SRX15596410 | MEF Embryonic fibroblast | 1285 / 13024 (9.9%) | 2837 / 130240 (2.2%) | −324.0 | −324.0 | 4.53 |
| Foxp1 SRX20851843 | CD8+ T cells Blood | 1583 / 13024 (12.2%) | 3495 / 130240 (2.7%) | −324.0 | −324.0 | 4.53 |
| Bcor SRX22719796 | Leukemia Blood | 2204 / 13024 (16.9%) | 4871 / 130240 (3.7%) | −324.0 | −324.0 | 4.52 |
| Nipbl SRX8694065 | B cells Blood | 2173 / 13024 (16.7%) | 4804 / 130240 (3.7%) | −324.0 | −324.0 | 4.52 |
| Nipbl SRX8694067 | B cells Blood | 1664 / 13024 (12.8%) | 3679 / 130240 (2.8%) | −324.0 | −324.0 | 4.52 |
| Tet2 SRX4232706 | Hematopoietic cells Blood | 1233 / 13024 (9.5%) | 2728 / 130240 (2.1%) | −324.0 | −324.0 | 4.52 |
| Ets1 SRX2499705 | Scid.adh.2c2 Blood | 2766 / 13024 (21.2%) | 6121 / 130240 (4.7%) | −324.0 | −324.0 | 4.52 |
| Tcf3 SRX1568865 | Unclassified Unclassified | 1263 / 13024 (9.7%) | 2795 / 130240 (2.1%) | −324.0 | −324.0 | 4.52 |
| Nipbl SRX8694063 | T cells Blood | 2159 / 13024 (16.6%) | 4786 / 130240 (3.7%) | −324.0 | −324.0 | 4.51 |
| Bcl11b SRX2487652 | CD4 CD8 double negative cells Blood | 3024 / 13024 (23.2%) | 6709 / 130240 (5.2%) | −324.0 | −324.0 | 4.51 |
| Spin1 SRX2704849 | Myoblasts Muscle | 1598 / 13024 (12.3%) | 3547 / 130240 (2.7%) | −324.0 | −324.0 | 4.51 |
| Foxp1 SRX20851844 | CD8+ T cells Blood | 1659 / 13024 (12.7%) | 3684 / 130240 (2.8%) | −324.0 | −324.0 | 4.50 |
| Kmt2a SRX25655409 | Leukemia Blood | 1340 / 13024 (10.3%) | 2977 / 130240 (2.3%) | −324.0 | −324.0 | 4.50 |
| Bcl11b SRX18851333 | Thymocytes Blood | 2378 / 13024 (18.3%) | 5305 / 130240 (4.1%) | −324.0 | −324.0 | 4.48 |
| Mta2 SRX3660791 | Scid.adh.2c2 Blood | 1200 / 13024 (9.2%) | 2678 / 130240 (2.1%) | −324.0 | −324.0 | 4.48 |
| Kmt2a SRX25655413 | Leukemia Blood | 1495 / 13024 (11.5%) | 3337 / 130240 (2.6%) | −324.0 | −324.0 | 4.48 |
| Nipbl SRX3753617 | B cells Blood | 2182 / 13024 (16.8%) | 4871 / 130240 (3.7%) | −324.0 | −324.0 | 4.48 |
| Fli1 SRX4705104 | MLL-AF9 leukemic cell Blood | 1587 / 13024 (12.2%) | 3543 / 130240 (2.7%) | −324.0 | −324.0 | 4.48 |
| Runx1 SRX1438367 | EML Blood | 2776 / 13024 (21.3%) | 6202 / 130240 (4.8%) | −324.0 | −324.0 | 4.48 |
| Ets1 SRX2499704 | Scid.adh.2c2 Blood | 2718 / 13024 (20.9%) | 6084 / 130240 (4.7%) | −324.0 | −324.0 | 4.47 |
| Spi1 SRX5026213 | Mast Cells Blood | 1405 / 13024 (10.8%) | 3147 / 130240 (2.4%) | −324.0 | −324.0 | 4.46 |
| Epitope tags SRX9195293 | ES cells Pluripotent stem cell | 1259 / 13024 (9.7%) | 2823 / 130240 (2.2%) | −324.0 | −324.0 | 4.46 |
| Biotin SRX5578683 | ES cells Pluripotent stem cell | 1233 / 13024 (9.5%) | 2769 / 130240 (2.1%) | −324.0 | −324.0 | 4.45 |
| Bcl11b SRX18851331 | Thymocytes Blood | 2282 / 13024 (17.5%) | 5131 / 130240 (3.9%) | −324.0 | −324.0 | 4.45 |
| Elf1 SRX12734919 | Granulocyte-Macrophage Progenitor Cells Blood | 1312 / 13024 (10.1%) | 2951 / 130240 (2.3%) | −324.0 | −324.0 | 4.45 |
| Rag2 SRX1046541 | Thymocytes Blood | 2944 / 13024 (22.6%) | 6623 / 130240 (5.1%) | −324.0 | −324.0 | 4.45 |
| Spi1 SRX2499694 | Scid.adh.2c2 Blood | 1307 / 13024 (10.0%) | 2944 / 130240 (2.3%) | −324.0 | −324.0 | 4.44 |
| Brd4 SRX7799919 | CH12 Blood | 2316 / 13024 (17.8%) | 5220 / 130240 (4.0%) | −324.0 | −324.0 | 4.44 |
| Pax5 SRX19312225 | Pro-B cells Blood | 1933 / 13024 (14.8%) | 4360 / 130240 (3.3%) | −324.0 | −324.0 | 4.43 |
| Myc SRX353785 | B cells Blood | 2412 / 13024 (18.5%) | 5441 / 130240 (4.2%) | −324.0 | −324.0 | 4.43 |
| Kdm2b SRX22719855 | Leukemia Blood | 2402 / 13024 (18.4%) | 5436 / 130240 (4.2%) | −324.0 | −324.0 | 4.42 |
| Tmem131 SRX3219121 | RN2 Blood | 1371 / 13024 (10.5%) | 3108 / 130240 (2.4%) | −324.0 | −324.0 | 4.41 |
| Smarcc1 SRX8673307 | Tumor Others | 1224 / 13024 (9.4%) | 2775 / 130240 (2.1%) | −324.0 | −324.0 | 4.41 |
| Ep300 SRX1815530 | B cells Blood | 1187 / 13024 (9.1%) | 2693 / 130240 (2.1%) | −324.0 | −324.0 | 4.41 |
| Epitope tags SRX3219125 | RN2 Blood | 1479 / 13024 (11.4%) | 3359 / 130240 (2.6%) | −324.0 | −324.0 | 4.40 |
| Spi1 SRX5026212 | Mast Cells Blood | 1450 / 13024 (11.1%) | 3297 / 130240 (2.5%) | −324.0 | −324.0 | 4.40 |
| Pax5 SRX11976741 | Pro-B cells Blood | 2409 / 13024 (18.5%) | 5491 / 130240 (4.2%) | −324.0 | −324.0 | 4.39 |
| Wdr5 SRX1815529 | B cells Blood | 1882 / 13024 (14.5%) | 4291 / 130240 (3.3%) | −324.0 | −324.0 | 4.39 |
| Fli1 SRX1939439 | Lymphoid-primed multipotent progenitors Blood | 1833 / 13024 (14.1%) | 4181 / 130240 (3.2%) | −324.0 | −324.0 | 4.38 |
| Irf4 SRX1131942 | Plasmablasts Blood | 1333 / 13024 (10.2%) | 3042 / 130240 (2.3%) | −324.0 | −324.0 | 4.38 |
| Brd4 SRX376583 | MLL-AF9 leukemic cell Blood | 2125 / 13024 (16.3%) | 4854 / 130240 (3.7%) | −324.0 | −324.0 | 4.38 |
| Tcf3 SRX2162541 | Pre-B cells Blood | 1916 / 13024 (14.7%) | 4379 / 130240 (3.4%) | −324.0 | −324.0 | 4.38 |
| Fli1 SRX7821115 | Hematopoietic progenitors Blood | 1828 / 13024 (14.0%) | 4180 / 130240 (3.2%) | −324.0 | −324.0 | 4.37 |
| Nipbl SRX4895127 | CH12 Blood | 2598 / 13024 (19.9%) | 5941 / 130240 (4.6%) | −324.0 | −324.0 | 4.37 |
| Irf5 SRX3380964 | Dendritic Cells Blood | 1233 / 13024 (9.5%) | 2822 / 130240 (2.2%) | −324.0 | −324.0 | 4.37 |
| Cxxc1 SRX2486179 | ES cells Pluripotent stem cell | 1340 / 13024 (10.3%) | 3069 / 130240 (2.4%) | −324.0 | −324.0 | 4.37 |
| Runx3 SRX8718717 | T progenitor cells Blood | 2119 / 13024 (16.3%) | 4855 / 130240 (3.7%) | −324.0 | −324.0 | 4.36 |
| Spi1 SRX1465791 | B cells Blood | 1453 / 13024 (11.2%) | 3331 / 130240 (2.6%) | −324.0 | −324.0 | 4.36 |
| Fli1 SRX310201 | Mast Cells Blood | 2025 / 13024 (15.5%) | 4652 / 130240 (3.6%) | −324.0 | −324.0 | 4.35 |
| Bcl11b SRX18851328 | Thymocytes Blood | 2203 / 13024 (16.9%) | 5068 / 130240 (3.9%) | −324.0 | −324.0 | 4.35 |
| Nipbl SRX8694066 | B cells Blood | 1658 / 13024 (12.7%) | 3816 / 130240 (2.9%) | −324.0 | −324.0 | 4.34 |
| Nipbl SRX2755276 | B cells Blood | 2447 / 13024 (18.8%) | 5635 / 130240 (4.3%) | −324.0 | −324.0 | 4.34 |
| Hdac1 SRX9519542 | G1E Blood | 2134 / 13024 (16.4%) | 4917 / 130240 (3.8%) | −324.0 | −324.0 | 4.34 |
| Kmt2a SRX25655410 | Leukemia Blood | 1413 / 13024 (10.8%) | 3260 / 130240 (2.5%) | −324.0 | −324.0 | 4.33 |
| Egr2 SRX270570 | CD4+ T cells Blood | 1554 / 13024 (11.9%) | 3589 / 130240 (2.8%) | −324.0 | −324.0 | 4.33 |
| Med26 SRX20509320 | CH12 Blood | 2084 / 13024 (16.0%) | 4816 / 130240 (3.7%) | −324.0 | −324.0 | 4.33 |
| Rbfox2 SRX551545 | MEF Embryonic fibroblast | 1719 / 13024 (13.2%) | 3975 / 130240 (3.1%) | −324.0 | −324.0 | 4.32 |
| Hdac1 SRX7726755 | B cells Blood | 1871 / 13024 (14.4%) | 4334 / 130240 (3.3%) | −324.0 | −324.0 | 4.32 |
| GFP SRX2486159 | C127 Breast | 1945 / 13024 (14.9%) | 4509 / 130240 (3.5%) | −324.0 | −324.0 | 4.31 |
| Tcf7 SRX24130478 | Thymocytes Blood | 1407 / 13024 (10.8%) | 3262 / 130240 (2.5%) | −324.0 | −324.0 | 4.31 |
| Sin3a SRX22262962 | Beta-TC-6 Pancreas | 1239 / 13024 (9.5%) | 2881 / 130240 (2.2%) | −324.0 | −324.0 | 4.30 |
| Rag2 SRX1046545 | Thymocytes Blood | 3039 / 13024 (23.3%) | 7076 / 130240 (5.4%) | −324.0 | −324.0 | 4.29 |
| Kmt2a SRX17605411 | Leukemia Blood | 2309 / 13024 (17.7%) | 5380 / 130240 (4.1%) | −324.0 | −324.0 | 4.29 |
| Nipbl SRX3753614 | B cells Blood | 1676 / 13024 (12.9%) | 3913 / 130240 (3.0%) | −324.0 | −324.0 | 4.28 |
| Ikzf3 SRX10166890 | Thymocytes Blood | 2089 / 13024 (16.0%) | 4880 / 130240 (3.7%) | −324.0 | −324.0 | 4.28 |
| Crebbp SRX25655381 | Leukemia Blood | 2018 / 13024 (15.5%) | 4725 / 130240 (3.6%) | −324.0 | −324.0 | 4.27 |
| Tcf7 SRX24130479 | Thymocytes Blood | 1445 / 13024 (11.1%) | 3385 / 130240 (2.6%) | −324.0 | −324.0 | 4.27 |
| Cbfb SRX2389673 | Thymocytes Blood | 2160 / 13024 (16.6%) | 5062 / 130240 (3.9%) | −324.0 | −324.0 | 4.27 |
| Runx1 SRX2499762 | Scid.adh.2c2 Blood | 2256 / 13024 (17.3%) | 5295 / 130240 (4.1%) | −324.0 | −324.0 | 4.26 |
| Spi1 SRX3729397 | Hematopoietic progenitors Blood | 1287 / 13024 (9.9%) | 3024 / 130240 (2.3%) | −324.0 | −324.0 | 4.26 |
| Biotin SRX10950530 | Pro-B cells Blood | 1556 / 13024 (11.9%) | 3664 / 130240 (2.8%) | −324.0 | −324.0 | 4.25 |
| Runx1 SRX5358488 | Pro-B cells Blood | 1962 / 13024 (15.1%) | 4621 / 130240 (3.5%) | −324.0 | −324.0 | 4.25 |
| Spi1 SRX5026211 | Mast Cells Blood | 1607 / 13024 (12.3%) | 3785 / 130240 (2.9%) | −324.0 | −324.0 | 4.25 |
| Epitope tags SRX9195292 | ES cells Pluripotent stem cell | 1441 / 13024 (11.1%) | 3405 / 130240 (2.6%) | −324.0 | −324.0 | 4.23 |
| Runx1 SRX5358492 | Pro-B cells Blood | 3216 / 13024 (24.7%) | 7617 / 130240 (5.8%) | −324.0 | −324.0 | 4.22 |
| Pax5 SRX7809234 | Pro-B cells Blood | 1490 / 13024 (11.4%) | 3531 / 130240 (2.7%) | −324.0 | −324.0 | 4.22 |
| Biotin SRX3410337 | Pre-B cells Blood | 1367 / 13024 (10.5%) | 3242 / 130240 (2.5%) | −324.0 | −324.0 | 4.22 |
| Spi1 SRX091673 | CD4 CD8 double negative cells Blood | 1792 / 13024 (13.8%) | 4252 / 130240 (3.3%) | −324.0 | −324.0 | 4.21 |
| Fli1 SRX4705106 | MLL-AF9 leukemic cell Blood | 1491 / 13024 (11.4%) | 3546 / 130240 (2.7%) | −324.0 | −324.0 | 4.20 |
| Bach2 SRX2200545 | Pro-B cells Blood | 1868 / 13024 (14.3%) | 4446 / 130240 (3.4%) | −324.0 | −324.0 | 4.20 |
| Kdm1a SRX181863 | Granulocytes Blood | 1600 / 13024 (12.3%) | 3810 / 130240 (2.9%) | −324.0 | −324.0 | 4.20 |
| Bcor SRX22719813 | Leukemia Blood | 1781 / 13024 (13.7%) | 4242 / 130240 (3.3%) | −324.0 | −324.0 | 4.20 |
| Pax5 SRX7809235 | Pro-B cells Blood | 1500 / 13024 (11.5%) | 3574 / 130240 (2.7%) | −324.0 | −324.0 | 4.20 |
| Yy1 SRX14617702 | CH12 Blood | 1833 / 13024 (14.1%) | 4376 / 130240 (3.4%) | −324.0 | −324.0 | 4.19 |
| Spi1 SRX5026214 | Mast Cells Blood | 1602 / 13024 (12.3%) | 3833 / 130240 (2.9%) | −324.0 | −324.0 | 4.18 |
| Pax5 SRX7809233 | Pro-B cells Blood | 1372 / 13024 (10.5%) | 3283 / 130240 (2.5%) | −324.0 | −324.0 | 4.18 |
| Pax5 SRX19312224 | Pro-B cells Blood | 2480 / 13024 (19.0%) | 5938 / 130240 (4.6%) | −324.0 | −324.0 | 4.18 |
| Hdac1 SRX9519543 | G1E Blood | 2335 / 13024 (17.9%) | 5604 / 130240 (4.3%) | −324.0 | −324.0 | 4.17 |
| Sin3a SRX22262965 | Beta-TC-6 Pancreas | 1567 / 13024 (12.0%) | 3761 / 130240 (2.9%) | −324.0 | −324.0 | 4.17 |
| Pax5 SRX7809236 | Pro-B cells Blood | 1790 / 13024 (13.7%) | 4307 / 130240 (3.3%) | −324.0 | −324.0 | 4.16 |
| Smarca4 SRX7807053 | Embryonic liver Embryo | 2528 / 13024 (19.4%) | 6093 / 130240 (4.7%) | −324.0 | −324.0 | 4.15 |
| Spi1 SRX5026215 | Mast Cells Blood | 1668 / 13024 (12.8%) | 4024 / 130240 (3.1%) | −324.0 | −324.0 | 4.15 |
| Runx1 SRX1901620 | G1E Blood | 1547 / 13024 (11.9%) | 3734 / 130240 (2.9%) | −324.0 | −324.0 | 4.14 |
| Sin3a SRX22262966 | Beta-TC-6 Pancreas | 1636 / 13024 (12.6%) | 3951 / 130240 (3.0%) | −324.0 | −324.0 | 4.14 |
| Nipbl SRX2755277 | B cells Blood | 2733 / 13024 (21.0%) | 6602 / 130240 (5.1%) | −324.0 | −324.0 | 4.14 |
| Nfya SRX12799801 | Acute myeloid leukemia Blood | 1591 / 13024 (12.2%) | 3851 / 130240 (3.0%) | −324.0 | −324.0 | 4.13 |
| Spi1 SRX2499701 | Scid.adh.2c2 Blood | 1895 / 13024 (14.6%) | 4593 / 130240 (3.5%) | −324.0 | −324.0 | 4.13 |
| Runx1 SRX1901618 | G1E Blood | 1276 / 13024 (9.8%) | 3093 / 130240 (2.4%) | −324.0 | −324.0 | 4.13 |
| Rnf2 SRX9633976 | B cells Blood | 2067 / 13024 (15.9%) | 5011 / 130240 (3.8%) | −324.0 | −324.0 | 4.12 |
| Rag2 SRX1046553 | B cells Blood | 2982 / 13024 (22.9%) | 7237 / 130240 (5.6%) | −324.0 | −324.0 | 4.12 |
| Gata3 SRX2499768 | Scid.adh.2c2 Blood | 1832 / 13024 (14.1%) | 4447 / 130240 (3.4%) | −324.0 | −324.0 | 4.12 |
| Hdac1 SRX1815525 | B cells Blood | 3032 / 13024 (23.3%) | 7377 / 130240 (5.7%) | −324.0 | −324.0 | 4.11 |
| Nipbl SRX3753616 | B cells Blood | 2600 / 13024 (20.0%) | 6334 / 130240 (4.9%) | −324.0 | −324.0 | 4.10 |
| Epitope tags SRX838206 | Erythroblasts Blood | 1332 / 13024 (10.2%) | 3246 / 130240 (2.5%) | −324.0 | −324.0 | 4.10 |
| Bcl11b SRX3660780 | CD4 CD8 double negative cells Blood | 3366 / 13024 (25.8%) | 8207 / 130240 (6.3%) | −324.0 | −324.0 | 4.10 |
| Wdr5 SRX1815515 | B cells Blood | 1735 / 13024 (13.3%) | 4241 / 130240 (3.3%) | −324.0 | −324.0 | 4.09 |
| Runx1 SRX1892671 | 416B Blood | 1490 / 13024 (11.4%) | 3647 / 130240 (2.8%) | −324.0 | −324.0 | 4.09 |
| Ikzf1 SRX20340935 | Pre-B cells Blood | 1408 / 13024 (10.8%) | 3448 / 130240 (2.6%) | −324.0 | −324.0 | 4.08 |
| Chd8 SRX10111410 | ES cells Pluripotent stem cell | 1287 / 13024 (9.9%) | 3154 / 130240 (2.4%) | −324.0 | −324.0 | 4.08 |
| Bcl11b SRX18851330 | Thymocytes Blood | 2654 / 13024 (20.4%) | 6505 / 130240 (5.0%) | −324.0 | −324.0 | 4.08 |
| Bcl11b SRX18851329 | Thymocytes Blood | 2684 / 13024 (20.6%) | 6583 / 130240 (5.1%) | −324.0 | −324.0 | 4.08 |
| Spi1 SRX2499724 | Scid.adh.2c2 Blood | 1709 / 13024 (13.1%) | 4195 / 130240 (3.2%) | −324.0 | −324.0 | 4.07 |
| Smarca4 SRX7807050 | Embryonic liver Embryo | 2640 / 13024 (20.3%) | 6483 / 130240 (5.0%) | −324.0 | −324.0 | 4.07 |
| Mta2 SRX3660756 | CD4 CD8 double negative cells Blood | 1865 / 13024 (14.3%) | 4591 / 130240 (3.5%) | −324.0 | −324.0 | 4.06 |
| Ikzf1 SRX2162555 | Pre-B cells Blood | 1411 / 13024 (10.8%) | 3479 / 130240 (2.7%) | −324.0 | −324.0 | 4.06 |
| Kdm6b SRX621433 | CD4+ T cells Blood | 1707 / 13024 (13.1%) | 4211 / 130240 (3.2%) | −324.0 | −324.0 | 4.05 |
| Runx3 SRX4677010 | Innate lymphoid cells Blood | 1342 / 13024 (10.3%) | 3311 / 130240 (2.5%) | −324.0 | −324.0 | 4.05 |
| Hdac2 SRX3660790 | Scid.adh.2c2 Blood | 2453 / 13024 (18.8%) | 6056 / 130240 (4.6%) | −324.0 | −324.0 | 4.05 |
| Nipbl SRX4895128 | CH12 Blood | 2894 / 13024 (22.2%) | 7151 / 130240 (5.5%) | −324.0 | −324.0 | 4.05 |
| Stat5a SRX15950931 | CD4+ T cells Blood | 1977 / 13024 (15.2%) | 4901 / 130240 (3.8%) | −324.0 | −324.0 | 4.03 |
| Kdm4b SRX7794503 | Mesenchymal stem cells Others | 1485 / 13024 (11.4%) | 3687 / 130240 (2.8%) | −324.0 | −324.0 | 4.03 |
| Hdac1 SRX7726756 | B cells Blood | 1993 / 13024 (15.3%) | 4951 / 130240 (3.8%) | −324.0 | −324.0 | 4.03 |
| Runx1 SRX3195533 | CD4 CD8 double negative cells Blood | 2429 / 13024 (18.7%) | 6035 / 130240 (4.6%) | −324.0 | −324.0 | 4.02 |
| Kmt2a SRX1815528 | B cells Blood | 2822 / 13024 (21.7%) | 7027 / 130240 (5.4%) | −324.0 | −324.0 | 4.02 |
| Mta2 SRX1205896 | CD4 CD8 double negative cells Blood | 2622 / 13024 (20.1%) | 6534 / 130240 (5.0%) | −324.0 | −324.0 | 4.01 |
| Cbfb SRX105447 | L8057 Blood | 1396 / 13024 (10.7%) | 3480 / 130240 (2.7%) | −324.0 | −324.0 | 4.01 |
| Tbp SRX22599847 | NIH/3T3 Embryonic fibroblast | 2041 / 13024 (15.7%) | 5088 / 130240 (3.9%) | −324.0 | −324.0 | 4.01 |
| Kdm2b SRX22719874 | Leukemia Blood | 1588 / 13024 (12.2%) | 3962 / 130240 (3.0%) | −324.0 | −324.0 | 4.01 |
| Mllt3 SRX1902738 | Acute myeloid leukemia Blood | 2135 / 13024 (16.4%) | 5328 / 130240 (4.1%) | −324.0 | −324.0 | 4.01 |
| Brd4 SRX8379041 | Macrophages Blood | 1898 / 13024 (14.6%) | 4737 / 130240 (3.6%) | −324.0 | −324.0 | 4.01 |
| Rnf2 SRX105448 | L8057 Blood | 1362 / 13024 (10.5%) | 3406 / 130240 (2.6%) | −324.0 | −324.0 | 4.00 |
| Spi1 SRX5026216 | Mast Cells Blood | 1940 / 13024 (14.9%) | 4881 / 130240 (3.7%) | −324.0 | −324.0 | 3.97 |
| Batf SRX10150718 | CD8+ T cells Blood | 1663 / 13024 (12.8%) | 4202 / 130240 (3.2%) | −324.0 | −324.0 | 3.96 |
| Tfap4 SRX554972 | CD8+ T cells Blood | 1873 / 13024 (14.4%) | 4745 / 130240 (3.6%) | −324.0 | −324.0 | 3.95 |
| Hdac2 SRX3660789 | Scid.adh.2c2 Blood | 2726 / 13024 (20.9%) | 6923 / 130240 (5.3%) | −324.0 | −324.0 | 3.94 |
| Bcl11b SRX3660779 | CD4 CD8 double negative cells Blood | 3626 / 13024 (27.8%) | 9215 / 130240 (7.1%) | −324.0 | −324.0 | 3.93 |
| Rnf2 SRX9633974 | B cells Blood | 2244 / 13024 (17.2%) | 5708 / 130240 (4.4%) | −324.0 | −324.0 | 3.93 |
| Batf SRX10150717 | CD8+ T cells Blood | 1696 / 13024 (13.0%) | 4315 / 130240 (3.3%) | −324.0 | −324.0 | 3.93 |
| Spi1 SRX2499720 | Scid.adh.2c2 Blood | 1466 / 13024 (11.3%) | 3731 / 130240 (2.9%) | −324.0 | −324.0 | 3.93 |
| Pax5 SRX5358483 | Pro-B cells Blood | 1625 / 13024 (12.5%) | 4139 / 130240 (3.2%) | −324.0 | −324.0 | 3.93 |
| Nipbl SRX8694064 | T cells Blood | 2215 / 13024 (17.0%) | 5643 / 130240 (4.3%) | −324.0 | −324.0 | 3.93 |
| Pax5 SRX19312226 | Pro-B cells Blood | 2419 / 13024 (18.6%) | 6173 / 130240 (4.7%) | −324.0 | −324.0 | 3.92 |
| Brd4 SRX8379040 | Macrophages Blood | 1868 / 13024 (14.3%) | 4769 / 130240 (3.7%) | −324.0 | −324.0 | 3.92 |
| Kmt2a SRX17605408 | Monocytes Blood | 1385 / 13024 (10.6%) | 3536 / 130240 (2.7%) | −324.0 | −324.0 | 3.92 |
| Nfib SRX19694890 | C3H/10T1/2 Embryonic fibroblast | 1357 / 13024 (10.4%) | 3471 / 130240 (2.7%) | −324.0 | −324.0 | 3.91 |
| Mta2 SRX3660755 | CD4 CD8 double negative cells Blood | 2018 / 13024 (15.5%) | 5170 / 130240 (4.0%) | −324.0 | −324.0 | 3.90 |
| Kmt2a SRX1815514 | B cells Blood | 2956 / 13024 (22.7%) | 7574 / 130240 (5.8%) | −324.0 | −324.0 | 3.90 |
| Epitope tags SRX3219123 | RN2 Blood | 2918 / 13024 (22.4%) | 7478 / 130240 (5.7%) | −324.0 | −324.0 | 3.90 |
| Nipbl SRX4895106 | CH12 Blood | 2817 / 13024 (21.6%) | 7226 / 130240 (5.5%) | −324.0 | −324.0 | 3.90 |
| Kmt2a SRX17605409 | Monocytes Blood | 1559 / 13024 (12.0%) | 4000 / 130240 (3.1%) | −324.0 | −324.0 | 3.90 |
| Kdm2b SRX22719876 | Leukemia Blood | 2216 / 13024 (17.0%) | 5692 / 130240 (4.4%) | −324.0 | −324.0 | 3.89 |
| Runx3 SRX8718740 | T progenitor cells Blood | 2754 / 13024 (21.1%) | 7102 / 130240 (5.5%) | −324.0 | −324.0 | 3.88 |
| Chd4 SRX1815523 | B cells Blood | 3024 / 13024 (23.2%) | 7803 / 130240 (6.0%) | −324.0 | −324.0 | 3.88 |
| Zfp281 SRX16019903 | Th2 Cells Blood | 1852 / 13024 (14.2%) | 4783 / 130240 (3.7%) | −324.0 | −324.0 | 3.87 |
| Epitope tags SRX9195286 | ES cells Pluripotent stem cell | 1477 / 13024 (11.3%) | 3820 / 130240 (2.9%) | −324.0 | −324.0 | 3.87 |
| Runx2 SRX4705109 | MLL-AF9 leukemic cell Blood | 2280 / 13024 (17.5%) | 5902 / 130240 (4.5%) | −324.0 | −324.0 | 3.86 |
| Tcf3 SRX1568859 | B cells Blood | 1619 / 13024 (12.4%) | 4198 / 130240 (3.2%) | −324.0 | −324.0 | 3.86 |
| Rnf2 SRX3660767 | CD4 CD8 double negative cells Blood | 2190 / 13024 (16.8%) | 5688 / 130240 (4.4%) | −324.0 | −324.0 | 3.85 |
| Brd4 SRX2172627 | iPS cells Pluripotent stem cell | 1443 / 13024 (11.1%) | 3759 / 130240 (2.9%) | −324.0 | −324.0 | 3.84 |
| Bcl11b SRX12709528 | CD8+ T cells Blood | 2053 / 13024 (15.8%) | 5352 / 130240 (4.1%) | −324.0 | −324.0 | 3.84 |
| Gata3 SRX2499766 | Scid.adh.2c2 Blood | 1382 / 13024 (10.6%) | 3606 / 130240 (2.8%) | −324.0 | −324.0 | 3.83 |
| Yy1 SRX14617670 | CH12 Blood | 2375 / 13024 (18.2%) | 6199 / 130240 (4.8%) | −324.0 | −324.0 | 3.83 |
| Runx1 SRX5358482 | Pro-B cells Blood | 3272 / 13024 (25.1%) | 8545 / 130240 (6.6%) | −324.0 | −324.0 | 3.83 |
| Nipbl SRX3753615 | B cells Blood | 2553 / 13024 (19.6%) | 6690 / 130240 (5.1%) | −324.0 | −324.0 | 3.82 |
| Pax5 SRX11976740 | Pro-B cells Blood | 2266 / 13024 (17.4%) | 5948 / 130240 (4.6%) | −324.0 | −324.0 | 3.81 |
| Brd4 SRX884070 | MLL-AF9 leukemic cell Blood | 1580 / 13024 (12.1%) | 4148 / 130240 (3.2%) | −324.0 | −324.0 | 3.81 |
| Rbfox2 SRX551553 | MEF Embryonic fibroblast | 1635 / 13024 (12.6%) | 4301 / 130240 (3.3%) | −324.0 | −324.0 | 3.80 |
| Rnf2 SRX9633975 | B cells Blood | 2416 / 13024 (18.6%) | 6357 / 130240 (4.9%) | −324.0 | −324.0 | 3.80 |
| Ikzf3 SRX10166891 | Thymocytes Blood | 2117 / 13024 (16.3%) | 5571 / 130240 (4.3%) | −324.0 | −324.0 | 3.80 |
| Biotin SRX10950533 | B-ALL Blood | 1406 / 13024 (10.8%) | 3701 / 130240 (2.8%) | −324.0 | −324.0 | 3.80 |
| Stat4 SRX7726479 | Natural killer cells Blood | 2228 / 13024 (17.1%) | 5871 / 130240 (4.5%) | −324.0 | −324.0 | 3.79 |
| Egr2 SRX270569 | CD4+ T cells Blood | 1668 / 13024 (12.8%) | 4396 / 130240 (3.4%) | −324.0 | −324.0 | 3.79 |
| Spi1 SRX2499686 | CD25+ cells Blood | 2543 / 13024 (19.5%) | 6706 / 130240 (5.1%) | −324.0 | −324.0 | 3.79 |
| Spi1 SRX2499689 | CD25+ cells Blood | 1600 / 13024 (12.3%) | 4220 / 130240 (3.2%) | −324.0 | −324.0 | 3.79 |
| Smarca4 SRX7807052 | Embryonic liver Embryo | 2989 / 13024 (22.9%) | 7892 / 130240 (6.1%) | −324.0 | −324.0 | 3.79 |
| Pax5 SRX10950551 | Pro-B cells Blood | 2086 / 13024 (16.0%) | 5514 / 130240 (4.2%) | −324.0 | −324.0 | 3.78 |
| Myc SRX8012787 | Fibroblasts Others | 1514 / 13024 (11.6%) | 4003 / 130240 (3.1%) | −324.0 | −324.0 | 3.78 |
| Spi1 SRX2499688 | CD25+ cells Blood | 1612 / 13024 (12.4%) | 4272 / 130240 (3.3%) | −324.0 | −324.0 | 3.77 |
| Taf1 SRX19028407 | ES cells Pluripotent stem cell | 1751 / 13024 (13.4%) | 4643 / 130240 (3.6%) | −324.0 | −324.0 | 3.77 |
| Spi1 SRX7692793 | Eosinophils Blood | 1801 / 13024 (13.8%) | 4776 / 130240 (3.7%) | −324.0 | −324.0 | 3.77 |
| Yy1 SRX14617672 | CH12 Blood | 2434 / 13024 (18.7%) | 6458 / 130240 (5.0%) | −324.0 | −324.0 | 3.77 |
| Ash2l SRX4816218 | Dorsal cortex Neural | 1541 / 13024 (11.8%) | 4094 / 130240 (3.1%) | −324.0 | −324.0 | 3.76 |
| Spi1 SRX5026210 | Mast Cells Blood | 2304 / 13024 (17.7%) | 6140 / 130240 (4.7%) | −324.0 | −324.0 | 3.75 |
| Fli1 SRX203227 | Megakaryocytes Blood | 1493 / 13024 (11.5%) | 3979 / 130240 (3.1%) | −324.0 | −324.0 | 3.75 |
| Runx2 SRX4705110 | MLL-AF9 leukemic cell Blood | 2321 / 13024 (17.8%) | 6189 / 130240 (4.8%) | −324.0 | −324.0 | 3.75 |
| Cbfb SRX2389674 | Thymocytes Blood | 3363 / 13024 (25.8%) | 8977 / 130240 (6.9%) | −324.0 | −324.0 | 3.75 |
| Satb1 SRX13440924 | Thymus Blood | 2212 / 13024 (17.0%) | 5907 / 130240 (4.5%) | −324.0 | −324.0 | 3.74 |
| Pax5 SRX5358487 | Pro-B cells Blood | 1885 / 13024 (14.5%) | 5035 / 130240 (3.9%) | −324.0 | −324.0 | 3.74 |
| Elf1 SRX6783985 | CH12 Blood | 1441 / 13024 (11.1%) | 3850 / 130240 (3.0%) | −324.0 | −324.0 | 3.74 |
| Ikzf3 SRX10166888 | Thymocytes Blood | 1469 / 13024 (11.3%) | 3933 / 130240 (3.0%) | −324.0 | −324.0 | 3.74 |
| GFP SRX8244559 | Hematopoietic progenitors Blood | 3601 / 13024 (27.6%) | 9659 / 130240 (7.4%) | −324.0 | −324.0 | 3.73 |
| Cbfb SRX2389672 | Thymocytes Blood | 3453 / 13024 (26.5%) | 9276 / 130240 (7.1%) | −324.0 | −324.0 | 3.72 |
| Runx1 SRX1892679 | 416B Blood | 1496 / 13024 (11.5%) | 4019 / 130240 (3.1%) | −324.0 | −324.0 | 3.72 |
| Rnf2 SRX22719790 | Leukemia Blood | 1486 / 13024 (11.4%) | 4000 / 130240 (3.1%) | −324.0 | −324.0 | 3.71 |
| Sp1 SRX7799920 | CH12 Blood | 1438 / 13024 (11.0%) | 3878 / 130240 (3.0%) | −324.0 | −324.0 | 3.71 |
| Nfib SRX19694889 | C3H/10T1/2 Embryonic fibroblast | 1814 / 13024 (13.9%) | 4893 / 130240 (3.8%) | −324.0 | −324.0 | 3.71 |
| Epitope tags SRX9195279 | ES cells Pluripotent stem cell | 1629 / 13024 (12.5%) | 4395 / 130240 (3.4%) | −324.0 | −324.0 | 3.71 |
| Spi1 SRX340955 | FDCPmix Blood | 1547 / 13024 (11.9%) | 4178 / 130240 (3.2%) | −324.0 | −324.0 | 3.70 |
| Hdac2 SRX1815527 | B cells Blood | 3053 / 13024 (23.4%) | 8252 / 130240 (6.3%) | −324.0 | −324.0 | 3.70 |
| Runx1 SRX3195535 | CD4 CD8 double negative cells Blood | 2867 / 13024 (22.0%) | 7752 / 130240 (6.0%) | −324.0 | −324.0 | 3.70 |
| Spi1 SRX2499722 | Scid.adh.2c2 Blood | 1893 / 13024 (14.5%) | 5119 / 130240 (3.9%) | −324.0 | −324.0 | 3.70 |
| Smarca4 SRX7807051 | Embryonic liver Embryo | 3127 / 13024 (24.0%) | 8459 / 130240 (6.5%) | −324.0 | −324.0 | 3.70 |
| Nfib SRX19694891 | C3H/10T1/2 Embryonic fibroblast | 1944 / 13024 (14.9%) | 5261 / 130240 (4.0%) | −324.0 | −324.0 | 3.70 |
| Gata3 SRX2499769 | Scid.adh.2c2 Blood | 2561 / 13024 (19.7%) | 6946 / 130240 (5.3%) | −324.0 | −324.0 | 3.69 |
| Lmo2 SRX7821114 | Hematopoietic progenitors Blood | 2270 / 13024 (17.4%) | 6160 / 130240 (4.7%) | −324.0 | −324.0 | 3.69 |
| Hcfc1 SRX188798 | MEL Blood | 1811 / 13024 (13.9%) | 4917 / 130240 (3.8%) | −324.0 | −324.0 | 3.68 |
| Yy1 SRX14617701 | CH12 Blood | 2500 / 13024 (19.2%) | 6788 / 130240 (5.2%) | −324.0 | −324.0 | 3.68 |
| Stat4 SRX7726478 | Natural killer cells Blood | 2354 / 13024 (18.1%) | 6400 / 130240 (4.9%) | −324.0 | −324.0 | 3.68 |
| Kdm2b SRX22719878 | Leukemia Blood | 1865 / 13024 (14.3%) | 5081 / 130240 (3.9%) | −324.0 | −324.0 | 3.67 |
| Lmo2 SRX1939444 | Lymphoid-primed multipotent progenitors Blood | 2266 / 13024 (17.4%) | 6174 / 130240 (4.7%) | −324.0 | −324.0 | 3.67 |
| Taf1 SRX19028406 | ES cells Pluripotent stem cell | 1736 / 13024 (13.3%) | 4730 / 130240 (3.6%) | −324.0 | −324.0 | 3.67 |
| Med1 SRX1403503 | MLL-AF9 leukemic cell Blood | 1849 / 13024 (14.2%) | 5041 / 130240 (3.9%) | −324.0 | −324.0 | 3.67 |
| Hcfc1 SRX15939548 | NIH/3T3 Embryonic fibroblast | 1445 / 13024 (11.1%) | 3949 / 130240 (3.0%) | −324.0 | −324.0 | 3.66 |
| Spi1 SRX2499721 | Scid.adh.2c2 Blood | 2123 / 13024 (16.3%) | 5818 / 130240 (4.5%) | −324.0 | −324.0 | 3.65 |
| Kdm6b SRX621429 | CD4+ T cells Blood | 3119 / 13024 (23.9%) | 8551 / 130240 (6.6%) | −324.0 | −324.0 | 3.65 |
| Kdm2b SRX22719877 | Leukemia Blood | 2994 / 13024 (23.0%) | 8217 / 130240 (6.3%) | −324.0 | −324.0 | 3.64 |
| Max SRX9432515 | RAW 264.7 Blood | 2172 / 13024 (16.7%) | 5963 / 130240 (4.6%) | −324.0 | −324.0 | 3.64 |
| Stat4 SRX7726452 | Natural killer cells Blood | 1458 / 13024 (11.2%) | 4004 / 130240 (3.1%) | −324.0 | −324.0 | 3.64 |
| Yy1 SRX14617671 | CH12 Blood | 2528 / 13024 (19.4%) | 6948 / 130240 (5.3%) | −324.0 | −324.0 | 3.64 |
| Nfib SRX19694893 | C3H/10T1/2 Embryonic fibroblast | 1849 / 13024 (14.2%) | 5087 / 130240 (3.9%) | −324.0 | −324.0 | 3.63 |
| Kdm1a SRX5131516 | Medulloblastoma Neural | 1559 / 13024 (12.0%) | 4297 / 130240 (3.3%) | −324.0 | −324.0 | 3.63 |
| Nfib SRX19694894 | C3H/10T1/2 Embryonic fibroblast | 2000 / 13024 (15.4%) | 5515 / 130240 (4.2%) | −324.0 | −324.0 | 3.63 |
| Nr3c1 SRX4615042 | Lung endothelial cells Cardiovascular | 1977 / 13024 (15.2%) | 5454 / 130240 (4.2%) | −324.0 | −324.0 | 3.62 |
| Brd4 SRX1403500 | MLL-AF9 leukemic cell Blood | 2675 / 13024 (20.5%) | 7383 / 130240 (5.7%) | −324.0 | −324.0 | 3.62 |
| Yy1 SRX14617700 | CH12 Blood | 2465 / 13024 (18.9%) | 6815 / 130240 (5.2%) | −324.0 | −324.0 | 3.62 |
| Spi1 SRX1131940 | Plasmablasts Blood | 1935 / 13024 (14.9%) | 5352 / 130240 (4.1%) | −324.0 | −324.0 | 3.62 |
| Stat5a SRX17605414 | Leukemia Blood | 1771 / 13024 (13.6%) | 4900 / 130240 (3.8%) | −324.0 | −324.0 | 3.61 |
| Kmt2a SRX17605403 | Granulocytic-monocytic progenitors Blood | 3148 / 13024 (24.2%) | 8710 / 130240 (6.7%) | −324.0 | −324.0 | 3.61 |
| Smarca4 SRX1815522 | B cells Blood | 3539 / 13024 (27.2%) | 9817 / 130240 (7.5%) | −324.0 | −324.0 | 3.60 |
| Brd4 SRX1114541 | MLL-AF9 leukemic cell Blood | 3598 / 13024 (27.6%) | 9984 / 130240 (7.7%) | −324.0 | −324.0 | 3.60 |
| Spi1 SRX2499725 | Scid.adh.2c2 Blood | 2081 / 13024 (16.0%) | 5792 / 130240 (4.4%) | −324.0 | −324.0 | 3.59 |
| Rnf2 SRX3660769 | Bone Marrow Cells Blood | 2044 / 13024 (15.7%) | 5695 / 130240 (4.4%) | −324.0 | −324.0 | 3.59 |
| Irf4 SRX2162565 | Pre-B cells Blood | 2446 / 13024 (18.8%) | 6816 / 130240 (5.2%) | −324.0 | −324.0 | 3.59 |
| Ep300 SRX7726459 | Natural killer cells Blood | 1852 / 13024 (14.2%) | 5162 / 130240 (4.0%) | −324.0 | −324.0 | 3.59 |
| Kdm4c SRX1755829 | Granulocytic-monocytic progenitors Blood | 2037 / 13024 (15.6%) | 5680 / 130240 (4.4%) | −324.0 | −324.0 | 3.59 |
| Spi1 SRX2499687 | CD25+ cells Blood | 2555 / 13024 (19.6%) | 7135 / 130240 (5.5%) | −324.0 | −324.0 | 3.58 |
| Runx1 SRX825830 | mESC derived haematopoietic progenitor Pluripotent stem cell | 2001 / 13024 (15.4%) | 5588 / 130240 (4.3%) | −324.0 | −324.0 | 3.58 |
| Sap130 SRX1568882 | Embryonic heart Embryo | 2071 / 13024 (15.9%) | 5790 / 130240 (4.4%) | −324.0 | −324.0 | 3.58 |
| Bcl11b SRX663233 | Thymocytes Blood | 1629 / 13024 (12.5%) | 4555 / 130240 (3.5%) | −324.0 | −324.0 | 3.58 |
| Foxp3 SRX2341417 | Treg Blood | 1810 / 13024 (13.9%) | 5065 / 130240 (3.9%) | −324.0 | −324.0 | 3.57 |
| Rnf2 SRX3660768 | CD4 CD8 double negative cells Blood | 2529 / 13024 (19.4%) | 7083 / 130240 (5.4%) | −324.0 | −324.0 | 3.57 |
| Gfi1 SRX093162 | Bone Marrow Cells Blood | 1944 / 13024 (14.9%) | 5466 / 130240 (4.2%) | −324.0 | −324.0 | 3.56 |
| Spi1 SRX2341957 | Hematopoietic Stem Cells Blood | 1886 / 13024 (14.5%) | 5305 / 130240 (4.1%) | −324.0 | −324.0 | 3.56 |
| Spi1 SRX2341952 | LSK cells Blood | 1751 / 13024 (13.4%) | 4939 / 130240 (3.8%) | −324.0 | −324.0 | 3.55 |
| Taf1 SRX19028408 | ES cells Pluripotent stem cell | 1649 / 13024 (12.7%) | 4654 / 130240 (3.6%) | −324.0 | −324.0 | 3.54 |
| Nr3c1 SRX4615041 | Lung endothelial cells Cardiovascular | 1925 / 13024 (14.8%) | 5437 / 130240 (4.2%) | −324.0 | −324.0 | 3.54 |
| Ikzf1 SRX20340936 | Pre-B cells Blood | 1499 / 13024 (11.5%) | 4240 / 130240 (3.3%) | −324.0 | −324.0 | 3.54 |
| Med1 SRX1403504 | MLL-AF9 leukemic cell Blood | 1515 / 13024 (11.6%) | 4288 / 130240 (3.3%) | −324.0 | −324.0 | 3.53 |
| Chd4 SRX1815509 | B cells Blood | 1964 / 13024 (15.1%) | 5560 / 130240 (4.3%) | −324.0 | −324.0 | 3.53 |
| Mxi1 SRX140388 | CH12 Blood | 2267 / 13024 (17.4%) | 6421 / 130240 (4.9%) | −324.0 | −324.0 | 3.53 |
| Foxp3 SRX2341414 | Treg Blood | 1866 / 13024 (14.3%) | 5286 / 130240 (4.1%) | −324.0 | −324.0 | 3.53 |
| Pax5 SRX10950550 | Pro-B cells Blood | 2713 / 13024 (20.8%) | 7706 / 130240 (5.9%) | −324.0 | −324.0 | 3.52 |
| Bcl11b SRX2399085 | Thymocytes Blood | 3609 / 13024 (27.7%) | 10266 / 130240 (7.9%) | −324.0 | −324.0 | 3.52 |
| Spi1 SRX1686485 | Bone Marrow Cells Blood | 1521 / 13024 (11.7%) | 4334 / 130240 (3.3%) | −324.0 | −324.0 | 3.51 |
| Asxl1 SRX2837022 | Mesenchymal stem cells Others | 1639 / 13024 (12.6%) | 4687 / 130240 (3.6%) | −324.0 | −324.0 | 3.50 |
| Gata1 SRX18530084 | mESC derived erythroid cells Pluripotent stem cell | 1517 / 13024 (11.6%) | 4342 / 130240 (3.3%) | −324.0 | −324.0 | 3.49 |
| Phf8 SRX2396659 | Prostate Prostate | 2028 / 13024 (15.6%) | 5809 / 130240 (4.5%) | −324.0 | −324.0 | 3.49 |
| Ikzf3 SRX10166886 | Thymocytes Blood | 2252 / 13024 (17.3%) | 6453 / 130240 (5.0%) | −324.0 | −324.0 | 3.49 |
| Asxl1 SRX1471726 | Mesenchymal stem cells Others | 1637 / 13024 (12.6%) | 4691 / 130240 (3.6%) | −324.0 | −324.0 | 3.49 |
| Ikzf1 SRX205987 | B cells Blood | 2728 / 13024 (20.9%) | 7822 / 130240 (6.0%) | −324.0 | −324.0 | 3.49 |
| Sp1 SRX7799921 | CH12 Blood | 1823 / 13024 (14.0%) | 5246 / 130240 (4.0%) | −324.0 | −324.0 | 3.48 |
| Spi1 SRX2499723 | Scid.adh.2c2 Blood | 2183 / 13024 (16.8%) | 6285 / 130240 (4.8%) | −324.0 | −324.0 | 3.47 |
| Phf6 SRX1426206 | Pre-B cells Blood | 1627 / 13024 (12.5%) | 4687 / 130240 (3.6%) | −324.0 | −324.0 | 3.47 |
| Spi1 SRX2499696 | Scid.adh.2c2 Blood | 2323 / 13024 (17.8%) | 6696 / 130240 (5.1%) | −324.0 | −324.0 | 3.47 |
| Gfi1 SRX5131513 | Medulloblastoma Neural | 1862 / 13024 (14.3%) | 5377 / 130240 (4.1%) | −324.0 | −324.0 | 3.46 |
| Ncaph2 SRX1688321 | ES cells Pluripotent stem cell | 1818 / 13024 (14.0%) | 5263 / 130240 (4.0%) | −324.0 | −324.0 | 3.45 |
| Rnf2 SRX3660770 | Bone Marrow Cells Blood | 2197 / 13024 (16.9%) | 6373 / 130240 (4.9%) | −324.0 | −324.0 | 3.45 |
| Chd4 SRX3660751 | CD4 CD8 double negative cells Blood | 1963 / 13024 (15.1%) | 5704 / 130240 (4.4%) | −324.0 | −324.0 | 3.44 |
| Taf1 SRX11221947 | ES cells Pluripotent stem cell | 1729 / 13024 (13.3%) | 5025 / 130240 (3.9%) | −324.0 | −324.0 | 3.44 |
| Spi1 SRX2499695 | Scid.adh.2c2 Blood | 2709 / 13024 (20.8%) | 7896 / 130240 (6.1%) | −324.0 | −324.0 | 3.43 |
| Tcf12 SRX6784087 | CH12 Blood | 1564 / 13024 (12.0%) | 4572 / 130240 (3.5%) | −324.0 | −324.0 | 3.42 |
| Ikzf3 SRX10166889 | Thymocytes Blood | 3289 / 13024 (25.3%) | 9628 / 130240 (7.4%) | −324.0 | −324.0 | 3.42 |
| Cebpa SRX8005881 | Macrophages Blood | 1783 / 13024 (13.7%) | 5227 / 130240 (4.0%) | −324.0 | −324.0 | 3.41 |
| Kmt2a SRX17605404 | Granulocytic-monocytic progenitors Blood | 2526 / 13024 (19.4%) | 7430 / 130240 (5.7%) | −324.0 | −324.0 | 3.40 |
| Ikzf1 SRX205986 | B cells Blood | 3173 / 13024 (24.4%) | 9338 / 130240 (7.2%) | −324.0 | −324.0 | 3.40 |
| Phf8 SRX2396657 | Prostate Prostate | 2149 / 13024 (16.5%) | 6326 / 130240 (4.9%) | −324.0 | −324.0 | 3.40 |
| Runx3 SRX7554475 | CD8+ T cells Blood | 2633 / 13024 (20.2%) | 7778 / 130240 (6.0%) | −324.0 | −324.0 | 3.39 |
| Hcfc1 SRX188815 | CH12 Blood | 1919 / 13024 (14.7%) | 5675 / 130240 (4.4%) | −324.0 | −324.0 | 3.38 |
| Spi1 SRX340960 | FDCPmix Blood | 1631 / 13024 (12.5%) | 4826 / 130240 (3.7%) | −324.0 | −324.0 | 3.38 |
| Smc1a SRX7348142 | Thymocytes Blood | 2043 / 13024 (15.7%) | 6047 / 130240 (4.6%) | −324.0 | −324.0 | 3.38 |
| Tet1 SRX3202004 | ES cells Pluripotent stem cell | 1684 / 13024 (12.9%) | 4986 / 130240 (3.8%) | −324.0 | −324.0 | 3.38 |
| Gtf3c1 SRX1688327 | ES cells Pluripotent stem cell | 1617 / 13024 (12.4%) | 4792 / 130240 (3.7%) | −324.0 | −324.0 | 3.37 |
| Smarca4 SRX1815508 | B cells Blood | 3499 / 13024 (26.9%) | 10372 / 130240 (8.0%) | −324.0 | −324.0 | 3.37 |
| Ep300 SRX1565831 | Natural killer cells Blood | 2014 / 13024 (15.5%) | 5971 / 130240 (4.6%) | −324.0 | −324.0 | 3.37 |
| Myc SRX140397 | MEL Blood | 1590 / 13024 (12.2%) | 4714 / 130240 (3.6%) | −324.0 | −324.0 | 3.37 |
| Gtf3c1 SRX1688323 | ES cells Pluripotent stem cell | 1658 / 13024 (12.7%) | 4916 / 130240 (3.8%) | −324.0 | −324.0 | 3.37 |
| Med1 SRX1403502 | MLL-AF9 leukemic cell Blood | 2354 / 13024 (18.1%) | 6981 / 130240 (5.4%) | −324.0 | −324.0 | 3.37 |
| Smarca4 SRX8693962 | Neutrophils Blood | 2422 / 13024 (18.6%) | 7184 / 130240 (5.5%) | −324.0 | −324.0 | 3.37 |
| Epitope tags SRX2486173 | ES cells Pluripotent stem cell | 1778 / 13024 (13.7%) | 5286 / 130240 (4.1%) | −324.0 | −324.0 | 3.36 |
| Spi1 SRX2499682 | CD25+ cells Blood | 2098 / 13024 (16.1%) | 6239 / 130240 (4.8%) | −324.0 | −324.0 | 3.36 |
| Runx1 SRX310206 | Mast Cells Blood | 3196 / 13024 (24.5%) | 9507 / 130240 (7.3%) | −324.0 | −324.0 | 3.36 |
| Biotin SRX13366571 | Plasmablasts Blood | 1612 / 13024 (12.4%) | 4797 / 130240 (3.7%) | −324.0 | −324.0 | 3.36 |
| Smc1a SRX7348146 | CD4 CD8 double positive cells Blood | 2564 / 13024 (19.7%) | 7637 / 130240 (5.9%) | −324.0 | −324.0 | 3.36 |
| Smc1a SRX7348145 | CD4 CD8 double positive cells Blood | 2427 / 13024 (18.6%) | 7231 / 130240 (5.6%) | −324.0 | −324.0 | 3.36 |
| Rad21 SRX7481994 | Pro-B cells Blood | 1927 / 13024 (14.8%) | 5743 / 130240 (4.4%) | −324.0 | −324.0 | 3.36 |
| Ep300 SRX1565832 | Natural killer cells Blood | 1874 / 13024 (14.4%) | 5610 / 130240 (4.3%) | −324.0 | −324.0 | 3.34 |
| Spi1 SRX12298594 | B cells Blood | 1969 / 13024 (15.1%) | 5897 / 130240 (4.5%) | −324.0 | −324.0 | 3.34 |
| Biotin SRX13366572 | Plasmablasts Blood | 1840 / 13024 (14.1%) | 5513 / 130240 (4.2%) | −324.0 | −324.0 | 3.34 |
| Smc1a SRX7348143 | CD4 CD8 double positive cells Blood | 2510 / 13024 (19.3%) | 7532 / 130240 (5.8%) | −324.0 | −324.0 | 3.33 |
| Spi1 SRX5056010 | Hematopoietic progenitors Blood | 1754 / 13024 (13.5%) | 5272 / 130240 (4.0%) | −324.0 | −324.0 | 3.33 |
| Smc1a SRX7348141 | Thymocytes Blood | 2048 / 13024 (15.7%) | 6173 / 130240 (4.7%) | −324.0 | −324.0 | 3.32 |
| Kmt2d SRX17605389 | Granulocytic-monocytic progenitors Blood | 1682 / 13024 (12.9%) | 5080 / 130240 (3.9%) | −324.0 | −324.0 | 3.31 |
| Nipbl SRX8694047 | Neutrophils Blood | 1618 / 13024 (12.4%) | 4888 / 130240 (3.8%) | −324.0 | −324.0 | 3.31 |
| Mxi1 SRX140391 | MEL Blood | 2486 / 13024 (19.1%) | 7525 / 130240 (5.8%) | −324.0 | −324.0 | 3.30 |
| Spi1 SRX2499697 | Scid.adh.2c2 Blood | 2754 / 13024 (21.1%) | 8343 / 130240 (6.4%) | −324.0 | −324.0 | 3.30 |
| Sin3a SRX188801 | CH12 Blood | 2496 / 13024 (19.2%) | 7562 / 130240 (5.8%) | −324.0 | −324.0 | 3.30 |
| Ctcf SRX5086076 | Th2 Cells Blood | 1848 / 13024 (14.2%) | 5604 / 130240 (4.3%) | −324.0 | −324.0 | 3.30 |
| Max SRX140382 | MEL Blood | 1943 / 13024 (14.9%) | 5921 / 130240 (4.5%) | −324.0 | −324.0 | 3.28 |
| Ctcf SRX10095030 | Bone Marrow Cells Blood | 3223 / 13024 (24.7%) | 9827 / 130240 (7.5%) | −324.0 | −324.0 | 3.28 |
| Chd4 SRX3660753 | Bone Marrow Cells Blood | 2378 / 13024 (18.3%) | 7251 / 130240 (5.6%) | −324.0 | −324.0 | 3.28 |
| Spi1 SRX2341955 | Hematopoietic Stem Cells Blood | 2062 / 13024 (15.8%) | 6308 / 130240 (4.8%) | −324.0 | −324.0 | 3.27 |
| AML1-ETO SRX3491901 | Spleen Spleen | 2106 / 13024 (16.2%) | 6449 / 130240 (5.0%) | −324.0 | −324.0 | 3.27 |
| Brd9 SRX5689483 | nTreg Blood | 1704 / 13024 (13.1%) | 5218 / 130240 (4.0%) | −324.0 | −324.0 | 3.27 |
| Myc SRX140369 | CH12 Blood | 1700 / 13024 (13.1%) | 5238 / 130240 (4.0%) | −324.0 | −324.0 | 3.25 |
| Epitope tags SRX4042634 | Endometriotic lesions Uterus | 1942 / 13024 (14.9%) | 5987 / 130240 (4.6%) | −324.0 | −324.0 | 3.24 |
| Whsc1l1 SRX1114542 | MLL-AF9 leukemic cell Blood | 3058 / 13024 (23.5%) | 9428 / 130240 (7.2%) | −324.0 | −324.0 | 3.24 |
| Brd4 SRX1597806 | MLL-AF9 leukemic cell Blood | 2157 / 13024 (16.6%) | 6658 / 130240 (5.1%) | −324.0 | −324.0 | 3.24 |
| Smc1a SRX7348144 | CD4 CD8 double positive cells Blood | 2638 / 13024 (20.3%) | 8143 / 130240 (6.3%) | −324.0 | −324.0 | 3.24 |
| Gata3 SRX2499767 | Scid.adh.2c2 Blood | 2230 / 13024 (17.1%) | 6896 / 130240 (5.3%) | −324.0 | −324.0 | 3.23 |
| Tet1 SRX3202002 | ES cells Pluripotent stem cell | 1705 / 13024 (13.1%) | 5277 / 130240 (4.1%) | −324.0 | −324.0 | 3.23 |
| Spi1 SRX1056343 | 416B Blood | 2480 / 13024 (19.0%) | 7680 / 130240 (5.9%) | −324.0 | −324.0 | 3.23 |
| Spi1 SRX392743 | HAFTL Blood | 1710 / 13024 (13.1%) | 5307 / 130240 (4.1%) | −324.0 | −324.0 | 3.22 |
| Spi1 SRX886478 | B-ALL Blood | 3031 / 13024 (23.3%) | 9411 / 130240 (7.2%) | −324.0 | −324.0 | 3.22 |
| Rela SRX6074119 | MEF Embryonic fibroblast | 2585 / 13024 (19.8%) | 8069 / 130240 (6.2%) | −324.0 | −324.0 | 3.20 |
| AML1-ETO SRX3491900 | Spleen Spleen | 2389 / 13024 (18.3%) | 7462 / 130240 (5.7%) | −324.0 | −324.0 | 3.20 |
| Zfp384 SRX2324495 | Spermatogonia Gonad | 2069 / 13024 (15.9%) | 6466 / 130240 (5.0%) | −324.0 | −324.0 | 3.20 |
| Kmt2b SRX1602648 | ES cells Pluripotent stem cell | 1756 / 13024 (13.5%) | 5496 / 130240 (4.2%) | −324.0 | −324.0 | 3.20 |
| Mxi1 SRX15939545 | NIH/3T3 Embryonic fibroblast | 1811 / 13024 (13.9%) | 5672 / 130240 (4.4%) | −324.0 | −324.0 | 3.19 |
| Nipbl SRX8694051 | Neutrophils Blood | 1791 / 13024 (13.8%) | 5612 / 130240 (4.3%) | −324.0 | −324.0 | 3.19 |
| Taf1 SRX19028409 | ES cells Pluripotent stem cell | 1850 / 13024 (14.2%) | 5798 / 130240 (4.5%) | −324.0 | −324.0 | 3.19 |
Showing first 500 of 11490 rows.